Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pohlmann

Showing results (231-240 of 261) with videos related to

Pageof 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2025
Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast CancerMohamed A Gouda, Amrit Gonugunta, Ecaterina E Dumbrava, et al.
NPJ Breast Cancer|September 26, 2017
Video intervention increases participation of black breast cancer patients in therapeutic trialsBrandi N Robinson, Antoinette F Newman, Eshetu Tefera, et al.
Breast Cancer Research and Treatment|January 5, 2021
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart functionKatia Khoury, Filipa Lynce, Ana Barac, et al.
Breast Cancer Research and Treatment|September 20, 2022
Molecular characterization of ESR1 variants in breast cancerArielle L Heeke, Andrew Elliott, Rebecca Feldman, et al.
Plos One|September 22, 2010
Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinomaHiromitsu Hatakeyama, Haixia Cheng, Pamela Wirth, et al.
Reproductive Toxicology (Elmsford, N.Y.)|October 18, 2015
Tretinoin-loaded lipid-core nanocapsules decrease reactive oxygen species levels and improve bovine embryonic development during in vitro oocyte maturationCaroline Gomes Lucas, Mariana Härter Remião, Eliza Rossi Komninou, et al.
Cancers|March 29, 2023
Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFβ Signaling Pathways and <i>COP1</i> in MetastasisJerry Xiao, Utsav Sharma, Abolfazl Arab, et al.
Cancer Discovery|February 15, 2024
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived XenograftsTimothy P DiPeri, Kurt W Evans, Bailiang Wang, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 29, 2017
Effects of chitosan-coated lipid-core nanocapsules on bovine sperm cellsArthur de Castro Jorge Silva, Mariana Härter Remirão, Caroline Gomes Lucas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2024
Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trialL A Huppert, D Wolf, C Yau, et al.
Pageof 27

Showing results (231-240 of 261) with videos related to

Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2025
Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast CancerMohamed A Gouda, Amrit Gonugunta, Ecaterina E Dumbrava, et al.
NPJ Breast Cancer|September 26, 2017
Video intervention increases participation of black breast cancer patients in therapeutic trialsBrandi N Robinson, Antoinette F Newman, Eshetu Tefera, et al.
Breast Cancer Research and Treatment|January 5, 2021
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart functionKatia Khoury, Filipa Lynce, Ana Barac, et al.
Breast Cancer Research and Treatment|September 20, 2022
Molecular characterization of ESR1 variants in breast cancerArielle L Heeke, Andrew Elliott, Rebecca Feldman, et al.
Plos One|September 22, 2010
Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinomaHiromitsu Hatakeyama, Haixia Cheng, Pamela Wirth, et al.
Reproductive Toxicology (Elmsford, N.Y.)|October 18, 2015
Tretinoin-loaded lipid-core nanocapsules decrease reactive oxygen species levels and improve bovine embryonic development during in vitro oocyte maturationCaroline Gomes Lucas, Mariana Härter Remião, Eliza Rossi Komninou, et al.
Cancers|March 29, 2023
Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFβ Signaling Pathways and <i>COP1</i> in MetastasisJerry Xiao, Utsav Sharma, Abolfazl Arab, et al.
Cancer Discovery|February 15, 2024
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived XenograftsTimothy P DiPeri, Kurt W Evans, Bailiang Wang, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 29, 2017
Effects of chitosan-coated lipid-core nanocapsules on bovine sperm cellsArthur de Castro Jorge Silva, Mariana Härter Remirão, Caroline Gomes Lucas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2024
Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trialL A Huppert, D Wolf, C Yau, et al.
Pageof 27